Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 1.644
Filter
1.
Ultrastruct Pathol ; 46(1): 139-146, 2022 Jan 02.
Article in English | MEDLINE | ID: mdl-35105276

ABSTRACT

A case of poorly differentiated tubular gastric adenocarcinoma with tumor-associated tissue eosinophilia (TATE) is studied by light and electron microscopy, focusing on membrane interactions between eosinophils and tumor cells. 29.2% of the eosinophils in contact with tumor cells showed intact granules, 28.3% exhibited piecemeal degranulation (PMD), 40% were characterized by coexistence of PMD and compound exocytosis in the same granulocyte, whereas classical exocytosis was found in 2.5% of the eosinophils with PMD. Eosinophil Sombrero Vesicles (EoSVs), important tubulovesicular carriers for delivery of cytotoxic proteins from the specific granules during PMD, were also studied at the ultrastructural level. In activated eosinophils, EoSVs and specific granules with ultrastructural signs of degranulation were polarized toward tumor cells. Ultrastructural changes in paraptosis-like cell death, such as mitochondrial swelling, dilation of the nuclear envelope, cytoplasmic vacuoles, and nuclear chromatin condensation, but without margination of the chromatin, were observed in these tumor cells. Our data support the notion that eosinophils may exert an antitumoral role in gastric cancer. Finally, the case reported provides, for the first time, ultrastructural evidence of classical and compound exocytosis of eosinophils in the tumor stroma of human adenocarcinoma.


Subject(s)
Adenocarcinoma , Stomach Neoplasms , Adenocarcinoma/ultrastructure , Cytoplasmic Granules/pathology , Cytoplasmic Granules/ultrastructure , Eosinophils/metabolism , Eosinophils/ultrastructure , Exocytosis , Humans , Microscopy, Electron , Stomach Neoplasms/pathology
2.
Histopathology ; 80(3): 515-528, 2022 Feb.
Article in English | MEDLINE | ID: mdl-34605058

ABSTRACT

AIMS: Although evaluation of nuclear morphology is important for the diagnosis and categorisation of breast lesions, the criteria used to assess nuclear atypia rely upon the subjective evaluation of several features that may result in inter- and intraobserver variation. This study aims to refine the definitions of cytonuclear features in various breast lesions. METHODS AND RESULTS: ImageJ was used to assess the nuclear morphological features including nuclear diameter, axis length, perimeter, area, circularity and roundness in 160 breast lesions comprising ductal carcinoma in situ (DCIS), invasive breast carcinoma of no special type (IBC-NST), tubular carcinoma, usual ductal hyperplasia (UDH), columnar cell change (CCC) and flat epithelial atypia (FEA). Reference cells included normal epithelial cells, red blood cells (RBCs) and lymphocytes. Reference cells showed size differences not only between normal epithelial cells and RBCs but also between RBCs in varied-sized blood vessels. Nottingham grade nuclear pleomorphism scores 1 and 3 cut-offs in IBC-NST, compared to normal epithelial cells, were < ×1.2 and > ×1.4 that of mean maximum Feret's diameter and < ×1.6 and > ×2.4 that of mean nuclear area, respectively. Nuclear morphometrics were significantly different in low-grade IBC-NST versus tubular carcinoma, low-grade DCIS versus UDH and CCC versus FEA. No differences in the nuclear features between grade-matched DCIS and IBC-NST were identified. CONCLUSION: This study provides a guide for the assessment of nuclear atypia in breast lesions, refines the comparison with reference cells and highlights the potential diagnostic value of image analysis tools in the era of digital pathology.


Subject(s)
Adenocarcinoma , Carcinoma, Ductal, Breast , Carcinoma, Intraductal, Noninfiltrating , Cell Nucleus/pathology , Observer Variation , Adenocarcinoma/pathology , Adenocarcinoma/ultrastructure , Biopsy , Breast Neoplasms/pathology , Breast Neoplasms/ultrastructure , Carcinoma, Ductal, Breast/pathology , Carcinoma, Ductal, Breast/ultrastructure , Carcinoma, Intraductal, Noninfiltrating/pathology , Carcinoma, Intraductal, Noninfiltrating/ultrastructure , Epithelial Cells/pathology , Epithelial Cells/ultrastructure , Female , Humans , Hyperplasia/pathology
3.
Sci Rep ; 11(1): 6664, 2021 03 23.
Article in English | MEDLINE | ID: mdl-33758229

ABSTRACT

FLO-1 cell line represents an important tool in esophageal adenocarcinoma (EAC) research as a verified and authentic cell line to study the disease pathophysiology and antitumor drug screenings. Since in vitro characteristics of cells depend on the microenvironment and culturing conditions, we performed a thorough characterization of the FLO-1 cell line under different culturing conditions with the aim of (1) examining the effect of serum-free growth medium and air-liquid interface (A-L) culturing, which better reflect physiological conditions in vivo and (2) investigating the differentiation potential of FLO-1 cells to mimic the properties of the in vivo esophageal epithelium. Our study shows that the composition of the media influenced the morphological, ultrastructural and molecular characteristics of FLO-1 cells, such as the expression of junctional proteins. Importantly, FLO-1 cells formed spheres at the A-L interface, recapitulating key elements of tumors in the esophageal tube, i.e., direct contact with the gas phase and three-dimensional architecture. On the other hand, FLO-1 models exhibited high permeability to model drugs and zero permeability markers, and low transepithelial resistance, and therefore poorly mimicked normal esophageal epithelium. In conclusion, the identified effect of culture conditions on the characteristics of FLO-1 cells should be considered for standardization, data reproducibility and validity of the in vitro EAC model. Moreover, the sphere-forming ability of FLO-1 cells at the A-L interface should be considered in EAC tumor biology and anticancer drug studies as a reliable and straightforward model with the potential to increase the predictive efficiency of the current in vitro approaches.


Subject(s)
Adenocarcinoma/ultrastructure , Antineoplastic Agents/pharmacology , Cell Culture Techniques , Drug Screening Assays, Antitumor/methods , Drug Screening Assays, Antitumor/standards , Esophageal Neoplasms/ultrastructure , Adenocarcinoma/pathology , Cell Line, Tumor , Cell Proliferation/drug effects , Cell Survival/drug effects , Culture Media , Drug Discovery/methods , Esophageal Neoplasms/pathology , Humans , Immunohistochemistry , Intercellular Junctions/ultrastructure
4.
Microscopy (Oxf) ; 70(2): 192-200, 2021 Mar 24.
Article in English | MEDLINE | ID: mdl-32780825

ABSTRACT

Mini-abstract: Application of a three-dimensional culture system with air exposure facilitates the formation of large cell spheres possessing cribriform glands and producing mucin in the collagen gel. Transmission electron microscopy revealed the formation of microvilli and junctional complexes at the apical side of the cell. This study aimed to reproduce the characteristics of original adenocarcinoma tumors in vitro. The pancreatic cell line, SUIT-58, derived from a moderately differentiated adenocarcinoma of metastatic pancreatic cancer was used. The cells have a sheet structure in conventional cell culture without forming glands or exhibiting mucin production in the lumen. First, the necessity of scaffolds to create an adenocarcinoma-like microenvironment for SUIT-58 pancreatic cancer cells was assessed. Compared with conventional culture plates, the use of type I collagen as a scaffold played an important role in the formation of densely congested microvilli, as observed through scanning electron microscopy. As gland formation is one of the features of adenocarcinoma, we also assessed gland formation. Use of a recently developed three-dimensional culture system with air exposure resulted in the formation of large cell spheres possessing cribriform glands, which released mucin into the lumen. Transmission electron microscopy also revealed the formation of microvilli in the lumen of the glands and junctional complex at the intercellular part, which were similar to those observed in xenografts. These findings indicate that an in vitro three-dimensional culture system with air exposure reflects the intrinsic features of the original tumor, suggesting that this culture system could be useful for preliminary research of certain cancers.


Subject(s)
Adenocarcinoma/ultrastructure , Cell Culture Techniques , Microscopy, Electron, Scanning/methods , Microscopy, Electron, Transmission/methods , Pancreatic Neoplasms/ultrastructure , Adenocarcinoma/pathology , Humans , Pancreatic Neoplasms/pathology , Spheroids, Cellular , Tissue Scaffolds , Tumor Cells, Cultured , Tumor Microenvironment , Pancreatic Neoplasms
5.
Nanotechnology ; 31(18): 185102, 2020 May 01.
Article in English | MEDLINE | ID: mdl-31952056

ABSTRACT

Current conventional mono and combination therapeutic strategies often fail to target breast cancer tissue effectively due to tumor heterogeneity comprising cancer stem cells (CSCs) and bulk tumor cells. This is further associated with drug toxicity and resistivity in the long run. A nanomedicine platform incorporating combination anti-cancer treatment might overcome these challenges and generate synergistic anti-cancer effects and also reduce drug toxicity. GANT61 and curcumin were co-delivered via polymeric nanoparticles (NPs) for the first time to elicit enhanced anti-tumor activity against heterogeneous breast cancer cell line MCF-7. We adopted the single-emulsion-solvent evaporation method for the preparation of the therapeutic NPs. The GANT61-curcumin PLGA NPs were characterized for their size, shape and chemical properties, and anti-cancer cell studies were undertaken for the plausible explanation of our hypothesis. The synthesized GANT61-curcumin PLGA NPs had a spherical, smooth surface morphology, and an average size of 347.4 d. nm. The NPs induced cytotoxic effects in breast cancer cells at a mid-minimal dosage followed by cell death via autophagy and apoptosis, reduction in their target protein expression along with compromising the self-renewal property of CSCs as revealed by their in vitro cell studies. The dual-drug NPs thus provide a novel perspective on aiding existing anti-cancer nanomedicine therapies to target a heterogeneous tumor mass effectively.


Subject(s)
Breast Neoplasms/drug therapy , Curcumin/therapeutic use , Nanoparticles/chemistry , Phosphatidylinositol 3-Kinases/metabolism , Polylactic Acid-Polyglycolic Acid Copolymer/chemistry , Proto-Oncogene Proteins c-akt/metabolism , Pyridines/therapeutic use , Pyrimidines/therapeutic use , Zinc Finger Protein GLI1/metabolism , Adenocarcinoma/drug therapy , Adenocarcinoma/pathology , Adenocarcinoma/ultrastructure , Animals , Apoptosis/drug effects , Autophagy/drug effects , Breast Neoplasms/pathology , Breast Neoplasms/ultrastructure , Cell Line, Tumor , Cell Proliferation/drug effects , Cell Survival/drug effects , Curcumin/pharmacology , Drug Liberation , Endocytosis/drug effects , Female , Humans , MCF-7 Cells , Mice , Nanoparticles/ultrastructure , Particle Size , Photoelectron Spectroscopy , Pyridines/pharmacology , Pyrimidines/pharmacology , Spectroscopy, Fourier Transform Infrared , Spheroids, Cellular/drug effects , Spheroids, Cellular/pathology , Static Electricity
6.
Autophagy ; 16(3): 486-500, 2020 03.
Article in English | MEDLINE | ID: mdl-31177911

ABSTRACT

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and lethal malignancies. Given that macroautophagy/autophagy activation is prevalent in PDAC, the dual roles of autophagy could be involved in PDAC heterogeneity. In this work, we demonstrated that TGFB1 induced autophagic flux through SMAD4-dependent or SMAD4-independent pathways based on a distinct genetic context. In SMAD4-positive PDAC cells, TGFB1-induced autophagy promoted proliferation and inhibited migration by decreasing the nuclear translocation of SMAD4. Conversely, TGFB1-induced autophagy inhibited proliferation and promoted migration in SMAD4-negative cells through the regulation of MAPK/ERK activation. TGFB1 expression also positively correlated with LC3B expression in PDAC specimens. A high level of LC3B was associated with unfavorable overall survival (OS) and disease-free survival (DFS) in SMAD4-negative PDAC patients, although LC3B could not predict OS and DFS for the 110 PDAC patients. Thus, TGFB1-induced autophagy contributed to the different patterns of PDAC progression. This knowledge can aid in improving our understanding of the molecular classification of PDAC and might guide the development of therapeutic strategies for PDAC, especially for SMAD4-negative PDAC.Abbreviations: CDH1: cadherin 1; CDH2: cadherin 2; CI: combination index; CQ: chloroquine; DFS: disease-free survival; EMT: epithelial-to-mesenchymal transition; ERK: extracellular signal-regulated protein kinase; GFP: green fluorescent protein; IHC: immunohistochemistry; MAP1LC3B/LC3B: microtubule associated protein 1 light chain 3 beta; MAPK: mitogen-activated protein kinase; OS: overall survival; PBS: phosphate-buffered saline; PDAC: pancreatic ductal adenocarcinoma; RAP: rapamycin; RFP: red fluorescent protein; RT: room temperature; shRNA: short-hairpin RNA; SQSTM1: sequestosome 1; TCGA: The Cancer Genome Atlas; TEM: transmission electron microscopy; TGFB1: transforming growth factor beta 1; TMA: tissue microarray.


Subject(s)
Autophagy , Disease Progression , Pancreatic Neoplasms/pathology , Smad4 Protein/metabolism , Transforming Growth Factor beta1/metabolism , Adenocarcinoma/metabolism , Adenocarcinoma/pathology , Adenocarcinoma/ultrastructure , Carcinoma, Pancreatic Ductal/metabolism , Carcinoma, Pancreatic Ductal/pathology , Carcinoma, Pancreatic Ductal/ultrastructure , Cell Line, Tumor , Cell Nucleus/metabolism , Female , Humans , MAP Kinase Signaling System , Male , Microtubule-Associated Proteins/metabolism , Middle Aged , Pancreatic Neoplasms/metabolism , Pancreatic Neoplasms/ultrastructure , Prognosis , Sequestosome-1 Protein/metabolism , Pancreatic Neoplasms
7.
Angiogenesis ; 22(3): 441-455, 2019 08.
Article in English | MEDLINE | ID: mdl-31161471

ABSTRACT

The origin of blood and lymphatic vessels in high-grade serous adenocarcinoma of ovary (HGSOC) is uncertain. We evaluated the potential of cancer stem cells (CSCs) in HGSOC to contribute to their formation. Using spheroids as an in vitro model for CSCs, we have evaluated their role in primary malignant cells (PMCs) in ascites from previously untreated patients with HGSOC and cell lines. Spheroids from PMCs grown under specific conditions showed significantly higher expression of endothelial, pericyte and lymphatic endothelial markers. These endothelial and lymphatic cells formed tube-like structures, showed uptake of Dil-ac-LDL and expressed endothelial nitric oxide synthase confirming their endothelial phenotype. Electron microscopy demonstrated classical Weibel-Palade bodies in differentiated cells. Genetically, CSCs and the differentiated cells had a similar identity. Lineage tracking using green fluorescent protein transfected cancer cells in nude mice confirmed that spheroids grown in stem cell conditions can give rise to all three cells. Bevacizumab, a monoclonal antibody that targets vascular endothelial growth factor inhibited the differentiation of spheroids to endothelial cells in vitro. These results suggest that CSCs contribute to angiogenesis and lymphangiogenesis in serous adenocarcinoma of the ovary, which can be inhibited.


Subject(s)
Adenocarcinoma/pathology , Lymphangiogenesis , Neoplasms, Cystic, Mucinous, and Serous/pathology , Neoplastic Stem Cells/pathology , Neovascularization, Pathologic/pathology , Ovarian Neoplasms/pathology , Adenocarcinoma/blood supply , Adenocarcinoma/ultrastructure , Ascites/metabolism , Ascites/pathology , Bevacizumab/pharmacology , Bevacizumab/therapeutic use , Biomarkers, Tumor/metabolism , Blood Vessels/pathology , Cell Differentiation/drug effects , Cell Line, Tumor , Endothelial Cells/metabolism , Female , Humans , Neoplasm Proteins/metabolism , Neoplasms, Cystic, Mucinous, and Serous/blood supply , Neoplasms, Cystic, Mucinous, and Serous/ultrastructure , Neoplastic Stem Cells/ultrastructure , Ovarian Neoplasms/blood supply , Ovarian Neoplasms/ultrastructure , Pericytes/pathology , Platelet Endothelial Cell Adhesion Molecule-1/metabolism , Vascular Endothelial Growth Factor A/metabolism
8.
Virchows Arch ; 475(2): 245-249, 2019 Aug.
Article in English | MEDLINE | ID: mdl-30852641

ABSTRACT

BACKGROUND: Rhabdoid colorectal carcinoma (RC) is a rare lesion localized to the proximal colon of patients with a mean age at diagnosis of around 70 years. This tumor shows an aggressive behavior with an overall survival period shorter than 12 months. The diagnostic hallmark is the presence of rhabdoid cells. Alterations in chromatin remodeling (SMARCB1) and in the centrosome structure (CROCC) are reported in RC usually BRAFmut and MSI-H. RKO intestinal neoplastic cells culture (BRAFmut, SMARCB1wt, MSI-H) with CROCC knockdown exhibit rhabdoid features and develop prominent projections from the edge of the cell. METHODS: Here, we investigated two cases of CROCCmutSMARCB1wt RC by scanning and transmission electron microscopy (SEM, TEM). RESULTS: TEM confirmed the diagnostic presence of intermediate cytoplasmic filaments and nucleolar margination. SEM showed cellular protrusions (lamellipodia) in the intercellular spaces not evident at light microscopy. CONCLUSIONS: These protrusions CROCC-related might represent the pathogenetic mechanism underlying the rhabdoid aggressive behavior, independently of tumor staging. To our knowledge, the SEM technique was applied in the study of this neoplasm for the first time.


Subject(s)
Adenocarcinoma/ultrastructure , Colorectal Neoplasms/ultrastructure , Cytoskeletal Proteins/genetics , Rhabdoid Tumor/ultrastructure , Adenocarcinoma/genetics , Adenocarcinoma/pathology , Aged , Colorectal Neoplasms/genetics , Colorectal Neoplasms/pathology , Female , Humans , Microscopy, Electron , Pseudopodia/pathology , Pseudopodia/ultrastructure , Rhabdoid Tumor/genetics , Rhabdoid Tumor/pathology
9.
Biomaterials ; 192: 590-600, 2019 02.
Article in English | MEDLINE | ID: mdl-30553134

ABSTRACT

Pancreatic ductal adenocarcinoma (PDAC) is a destructive cancer with poor prognosis. Both novel therapeutic targets and approaches are needed to improve the overall survival of PDAC patients. MicroRNA-212 (miR-212) has been reported as a tumor suppressor in multiple cancers, but its definitive role and exact mechanism in the progression of pancreatic cancer is unclear. In this study, we developed a new chimeric peptide (PL-1) composed of plectin-1-targeted PDAC-specific and arginine-rich RNA-binding motifs which could condense miRNA to self-assemble supramolecular nanoparticles. These nanoparticles could deliver miR-212 into PDAC cells specifically and efficiently which also showed good stability in RNase and serum. Moreover, we demonstrated that PL-1/miR-212 nanoparticles could dramatically enhance the chemotherapeutic effect of doxorubicin for PDAC both in vitro and in vivo. In terms of mechanism, combined miR-212 intervention by PL-1/miR-212 nanoparticles resulted in obvious decrease of USP9X expression (ubiquitin specific peptidase 9, X-linked, USP9X) and eventually enhanced the doxorubicin induced apoptosis and autophagy of PDAC cells. These findings provide a new promising anti-cancer strategy via PL-1/miR-212 nanoparticles and identify miR-212/USP9X as a new potential target for future systemic therapy against human PDAC.


Subject(s)
Adenocarcinoma/drug therapy , Carcinoma, Pancreatic Ductal/drug therapy , Doxorubicin/therapeutic use , MicroRNAs/administration & dosage , Nanoparticles/chemistry , Pancreatic Neoplasms/drug therapy , Peptides/chemistry , Adenocarcinoma/pathology , Adenocarcinoma/ultrastructure , Amino Acid Sequence , Animals , Apoptosis/drug effects , Autophagy/drug effects , Base Sequence , Carcinoma, Pancreatic Ductal/pathology , Carcinoma, Pancreatic Ductal/ultrastructure , Cell Line, Tumor , Doxorubicin/pharmacology , Humans , Male , Mice, Nude , MicroRNAs/genetics , Nanoparticles/ultrastructure , Pancreatic Neoplasms/pathology , Pancreatic Neoplasms/ultrastructure , Ubiquitin Thiolesterase/metabolism
10.
Exp Mol Pathol ; 106: 17-26, 2019 02.
Article in English | MEDLINE | ID: mdl-30439350

ABSTRACT

Invadopodia, cancer cell protrusions with proteolytic activity, are functionally associated with active remodeling of the extracellular matrix. Here, we show that the invadopodia-related protein TKS5 is expressed in human pancreatic adenocarcinoma lines, and demonstrate that pancreatic cancer cells depend on TKS5 for invadopodia formation and function. Immunofluorescence staining of human pancreatic cancer cells reveals that TKS5 is a marker of mature and immature invadopodia. We also analyze the co-staining patterns of TKS5 and the commonly used invadopodia marker Cortactin, and find only partial co-localization of these two proteins at invadopodia, with a large fraction of TKS5-positive invadopodia lacking detectable levels of Cortactin. Whereas compelling evidence exist on the role of invadopodia as mediators of invasive migration in cultured cells and in animal models of cancer, these structures have never been detected inside human tumors. Here, using antibodies against TKS5 and Cortactin, we describe for the first time structures strongly resembling invadopodia in various paraffin-embedded human tumor surgical specimens from pancreas and other organs. Our results strongly suggest that invadopodia are present inside human tumors, and warrants further investigation on their regulation and occurrence in surgical specimens, and on the value of TKS5 antibodies as pathological research and diagnostic tools.


Subject(s)
Adaptor Proteins, Vesicular Transport/physiology , Adenocarcinoma/pathology , Neoplasm Proteins/physiology , Pancreatic Neoplasms/pathology , Podosomes/physiology , Adenocarcinoma/chemistry , Adenocarcinoma/surgery , Adenocarcinoma/ultrastructure , Adult , Aged , Cell Line, Tumor , Cortactin/analysis , Female , Fluorescent Antibody Technique, Direct , Humans , Male , Middle Aged , Neoplasm Invasiveness , Neoplasms/chemistry , Neoplasms/pathology , Pancreatic Neoplasms/chemistry , Pancreatic Neoplasms/surgery , Pancreatic Neoplasms/ultrastructure , Paraffin Embedding , Podosomes/chemistry , Podosomes/ultrastructure , RNA Interference , RNA, Small Interfering/genetics
11.
Saudi J Gastroenterol ; 24(5): 289-293, 2018.
Article in English | MEDLINE | ID: mdl-29806596

ABSTRACT

BACKGROUND/AIM: Gastric cancer is the third leading cause of cancer mortality worldwide. Human epidermal growth factor (Her-2/neu) has shown strong therapeutic implication in breast cancer. Although the prevalence of Her-2/neu over-expression in gastric cancer has been reported across the world, it is still unknown from South Asia. The aim of this study is to evaluate Her-2/neu expression in gastric adenocarcinomas and to correlate with various clinicopathological variables. PATIENTS AND METHODS: A total of 95 consecutive patients undergoing endoscopic biopsy or gastrectomy were recruited in this study. Clinicopathological parameters of all patients were recorded and hematoxylin and eosin (H and E) staining was performed. Over-expression of Her-2/neu was investigated by immunohistochemistry using α-Her-2 antibody. To quantify Her-2/neu over-expression, the Hofmann validation scoring system was used and further its association was seen with age, gender, histopathological type, grade, and stage of the tumor. Data were entered and analyzed using SPSS version 21. A P value of <0.05 was considered as significant. RESULTS: Overall, 21 (22.1%) cases were positive for Her-2/neu overexpression from the total of 95 gastric adenocarcinomas. Her-2/neu was significantly expressed in low-grade gastric cancer (grade I = 50%, grade II = 34.5%, grade III = 14.5%; P = 0.030). Although there was insignificant difference between Her-2/neu over expression and other variables, Her-2/neu score 3+ was predominantly seen in females, age >60 years, Laurens intestinal type, and IIIC stage tumors. CONCLUSION: Her-2/neu is over-expressed in a limited group of gastric cancer patients in our population and indicates a significant strong association with low grades of gastric cancer.


Subject(s)
Adenocarcinoma/metabolism , Receptor, ErbB-2/metabolism , Stomach Neoplasms/metabolism , Stomach/pathology , Adenocarcinoma/pathology , Adenocarcinoma/ultrastructure , Adult , Aged , Aged, 80 and over , Biopsy , Endoscopy/methods , Female , Gastrectomy/methods , Humans , Immunohistochemistry/methods , Male , Middle Aged , Neoplasm Staging/methods , Pakistan/epidemiology , Stomach Neoplasms/pathology , Stomach Neoplasms/ultrastructure
12.
Histopathology ; 73(3): 521-528, 2018 Sep.
Article in English | MEDLINE | ID: mdl-29688587

ABSTRACT

AIMS: Gut-associated lymphoid tissue (GALT) carcinoma is a rare colorectal tumour that arises in the epithelium covering GALT. GALT carcinoma is a differentiated tubular adenocarcinoma with dense lymphoid tissue with a characteristically well-demarcated margin. To date, 26 cases of GALT carcinoma, including the three cases discussed here, have been reported. Most (24 of 26) were discovered at early stages and none of the cases have documented any metastases. This suggests that GALT carcinoma may have a favourable prognosis. It is hypothesised that GALT carcinoma originates from M cells in specialised epithelia covering GALT. However, this hypothesis has yet to be confirmed. METHODS AND RESULTS: In this study, we examined three cases of GALT carcinoma by immunohistochemistry detection of glycoprotein 2, a specific marker for M cells, and electron microscopy. Our findings showed that the tumour cells of GALT carcinoma in all three cases were negative for M cells. We thus concluded that GALT carcinoma may be a tubular adenocarcinoma arising by chance in the GALT. This unique carcinoma is a diferentiated adenocarcinoma that grows slowly with the development of GALT. CONCLUSIONS: We propose that GALT carcinoma should be classified separately because of its histological setting and good prognosis.


Subject(s)
Adenocarcinoma/pathology , Colorectal Neoplasms/pathology , Intestinal Mucosa/pathology , Adenocarcinoma/ultrastructure , Aged , Biomarkers, Tumor/analysis , Colorectal Neoplasms/ultrastructure , Female , Humans , Immunohistochemistry , Intestinal Mucosa/ultrastructure , Male , Microscopy, Electron, Transmission , Middle Aged
13.
Vet Pathol ; 55(4): 501-509, 2018 07.
Article in English | MEDLINE | ID: mdl-29444629

ABSTRACT

Vaginal and vulvar tumors are uncommon in dogs. Knowledge of canine primary clitoral neoplasia is restricted to a few case reports, and only carcinomas have been reported. Cytologic and histologic features reported in the literature seem to overlap with those of canine apocrine gland anal sac adenocarcinoma (AGASA). Clinical features also recall those of canine AGASA, such as locoregional metastases and hypercalcemia of malignancy (HM). In this study, 6 cases of primary canine clitoral carcinomas (CCCs), with and without HM, were investigated by means of cytology, histopathology, electron microscopy, and immunohistochemistry for neuroendocrine markers including chromogranin A (CGA), synaptophysin (SYN), neuron-specific enolase (NSE), and S-100. In all 6 tumors, cytologic findings were consistent with malignant epithelial neoplasia of apocrine gland origin. The tumors examined were classified into 3 different histological patterns representing different degrees of differentiation: tubular, solid, and rosette type. Both CGA and SYN were mildly expressed in 2 of 6 tumors, while NSE was consistently expressed in all 6 cases. None of the tumors were S-100 positive. Transmission electron microscopy revealed electron-dense cytoplasmic granules compatible with neuroendocrine granules in all 6 cases. CCCs presented clinicopathologic features resembling AGASAs with neuroendocrine characteristics, and 2 of 6 neoplasms were considered as carcinomas with neuroendocrine differentiation and were positive for 3 neuroendocrine markers. CCCs can often present with HM, and long-term outcome is likely poor. Our study concludes that CCC seems to be a rare tumor, but it might be underestimated because of the overlapping features with AGASA. Further studies should aim to define the true incidence of this disease.


Subject(s)
Adenocarcinoma/pathology , Biomarkers, Tumor/analysis , Carcinoma/veterinary , Dog Diseases/pathology , Hypercalcemia/veterinary , Paraneoplastic Syndromes/veterinary , Adenocarcinoma/diagnosis , Adenocarcinoma/surgery , Adenocarcinoma/ultrastructure , Animals , Carcinoma/diagnosis , Carcinoma/pathology , Carcinoma/ultrastructure , Chromogranin A/analysis , Clitoris/pathology , Dog Diseases/diagnosis , Dog Diseases/surgery , Dogs , Female , Hypercalcemia/diagnosis , Hypercalcemia/pathology , Immunohistochemistry/veterinary , Paraneoplastic Syndromes/diagnosis , Paraneoplastic Syndromes/pathology , Synaptophysin/analysis , Vulva/pathology
14.
Ultrastruct Pathol ; 42(2): 81-90, 2018.
Article in English | MEDLINE | ID: mdl-29419351

ABSTRACT

In this study, we describe, compare, and discuss several subcellular alterations found in Colorectal Adenocarcinoma and peritumoral tissue using transmission electron microscopy, morphometry, and statistical analysis. Tissue samples from anterior resections were collected from patients diagnosed with Colorectal Adenocarcinoma in the University Hospital of Caracas. Samples were processed according to the typical protocol for their observation through transmission electron microscopy. The resulting images were analyzed using specialized software for the collection of morphometric data. Several anomalies were common for both tissues, including but not limited to, rough endoplasmic reticulum and mitochondrial swelling, nuclear invagination, nuclear enlargement, and cellular swelling. In general, alterations within the tumor were more frequent and intense. Extensive organellar degradation and other evidences of cellular damage seemed to extend past the edge of the tumor into the peritumoral tissue. There seems to be a clear process of lateral cancerization present in the peritumoral area. The tissue layers composed of smooth muscle cells, probably due to their structural features, may allow greater diffusion of harmful substances produced by the tumor. A more in-depth analysis of peritumoral tissue considering organellar damage and morphometric data may provide relevant insight about the changing microenvironment promoted by the close proximity of a tumor.


Subject(s)
Adenocarcinoma/pathology , Adenocarcinoma/ultrastructure , Colorectal Neoplasms/pathology , Colorectal Neoplasms/ultrastructure , Aged , Humans , Image Interpretation, Computer-Assisted/methods , Male , Microscopy, Electron, Transmission/methods , Middle Aged
15.
Zhonghua Bing Li Xue Za Zhi ; 46(5): 318-322, 2017 May 08.
Article in Chinese | MEDLINE | ID: mdl-28468037

ABSTRACT

Objective: To investigate the clinicopathologic features of microcystic, elongated and fragmented (MELF) pattern invasion of endometrial adenocarcinoma. Methods: HE and immunohistochemistry staining method were used to analysis morphologic features and immunophenotype of 72 patients of endometrial adenocarcinoma with MELF pattern invasion, and chi-square test was used to analysis the clinicopathologic features. Results: The mean age of 72 patients was 54 years (40 to 70 years). Thirty-two patients were pre-menopausal and 40 were post-menopausal. According to the FIGO staging system (2014), 32 cases(44.4%)were at stage Ⅰ, 22 cases(30.6%)at stage Ⅱ, 17 cases(23.6%)at stage Ⅲ and 1 case(1.4%) at stage Ⅳ. Microscopically, MELF invasion showed microcystic, elongated slit-like or fragmented glands in myometrium and their lining cells usually were cube or flat, as well as the single or clusters of eosinophilic tumor cells mimicking histocytes. In addition, a fibromyxoid or inflammatory stromal response was often present.Immunohistochemical staining showed that MELF invasion was positive for p16, CA125 and CA19-9, but negative for ER, PR and p53.Compared with non-MELF pattern invasion, significant differences were noted in menopause pausimenia, FIGO stages, deep invasion into myometrium, lymph metastasis, lymphovascular space invasion (LVSL), serum CA125 and CA19-9 in patients with MELF pattern invasion (all P<0.05). Conclusions: MELF pattern invasion of endometrial adenocarcinoma is characterized by advanced FIGO stage, deep myoinvasion, high metastasis rate to lymph node and LVSL. Pathologists should recognize the MELF invasion and evaluate the depth of myometrium of infiltration and LVSL with special attention to the presence of MELF invasion with necessary immunohistochemistry for more accurate pathological diagnosis.


Subject(s)
Adenocarcinoma/pathology , Endometrial Neoplasms/pathology , Adenocarcinoma/blood , Adenocarcinoma/chemistry , Adenocarcinoma/ultrastructure , Adult , Aged , Chi-Square Distribution , Endometrial Neoplasms/blood , Endometrial Neoplasms/chemistry , Endometrial Neoplasms/ultrastructure , Female , Histiocytes/pathology , Humans , Immunohistochemistry , Immunophenotyping , Lymph Nodes , Lymphatic Metastasis , Middle Aged , Myometrium/chemistry , Myometrium/pathology , Neoplasm Invasiveness
16.
Folia Histochem Cytobiol ; 55(1): 6-10, 2017.
Article in English | MEDLINE | ID: mdl-28509311

ABSTRACT

INTRODUCTION: It have been found previously that colorectal cancer (CRC) is accompanied by atrophy of myenteric plexuses (MPs) localized close to the tumor. The aim of the study was to compare ultrastructure of MPs localized in the unchanged part of the colon wall distant to CRC tumor with the ultrastructure of MPs in the vicinity of CRC tumor. MATERIAL AND METHODS: The present study was conducted using post-operative material derived from 11 patients with CRC. Samples of colon wall were taken from the margin of cancer invasion and from a macroscopically unchanged segment of the large intestine, immediately fixed and processed according to the standard protocol for transmission electron microscopy studies. RESULTS: In the MPs localized in the control part of colon wall the presence of numerous unmyelinated axons and cell bodies of neurons, interstitial cells of Cajal and enteroglial cells were observed. As compared to control samples, in the MPs located close to the tumor invasion, expansion of the extracellular matrix and myelin-like structures accompanying some nerve fibers were found. The appearance of mast and plasma cells was observed within MPs in the vicinity of CRC tumor. Sporadically, apoptotic cells were present inside the MPs. CONCLUSIONS: The presence of myelin-like structures and apoptotic cells within MPs located close to tumor invasion suggests that atrophy of MPs may be caused by factors released from CRC tumor.


Subject(s)
Adenocarcinoma/pathology , Colon/ultrastructure , Colorectal Neoplasms/pathology , Myenteric Plexus/ultrastructure , Adenocarcinoma/ultrastructure , Aged , Colorectal Neoplasms/ultrastructure , Female , Humans , Male , Myenteric Plexus/pathology
17.
Sci Rep ; 7: 42339, 2017 02 15.
Article in English | MEDLINE | ID: mdl-28198398

ABSTRACT

The cancer drug gemcitabine (GEM) is a key drug for treating pancreatic ductal adenocarcinoma (PDAC), but PDAC cells develop chemoresistance after long-term administration. Since the tolerance was immediately spread to every PDAC tissue in a patient, it is assumed that some certain efficient mechanisms underlay in the development of chemoresistance. Changes in the levels of particular microRNAs or alterations in intercellular communication play a dominant role in chemoresistance development, and recent data also suggest that exosomes play an important role in this process. In this study, we revealed that the loop conferred chemoresistance in PDAC cells. The loop was as follows; 1, The long-term exposure of GEM increased miR-155 expression in PDAC cells. 2, The increase of miR-155 induced two different functions; exosome secretion and chemoresistance ability via facilitating the anti-apoptotic activity. 3, Exosome deliver the miR-155 into the other PDAC cells and induce the following function. The target therapy to miR-155 or the exosome secretion effectively attenuated the chemoresistance, and these results were validated with both clinical samples and in vivo experiments. This mechanism represents a novel therapeutic target in GEM treatment to PDAC.


Subject(s)
Adenocarcinoma/drug therapy , Antineoplastic Agents/therapeutic use , Carcinoma, Pancreatic Ductal/drug therapy , Deoxycytidine/analogs & derivatives , Drug Resistance, Neoplasm , Exosomes/metabolism , MicroRNAs/metabolism , Pancreatic Neoplasms/drug therapy , Adenocarcinoma/genetics , Adenocarcinoma/pathology , Adenocarcinoma/ultrastructure , Animals , Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Apoptosis/genetics , Carcinoma, Pancreatic Ductal/genetics , Carcinoma, Pancreatic Ductal/pathology , Carcinoma, Pancreatic Ductal/ultrastructure , Cell Line, Tumor , Deoxycytidine/pharmacology , Deoxycytidine/therapeutic use , Exosomes/drug effects , Gene Expression Regulation, Neoplastic/drug effects , Humans , Mice , MicroRNAs/genetics , Microdissection , Pancreatic Neoplasms/genetics , Pancreatic Neoplasms/pathology , Pancreatic Neoplasms/ultrastructure , Prognosis , Time Factors , Up-Regulation/drug effects , Up-Regulation/genetics , Xenograft Model Antitumor Assays , Gemcitabine , Pancreatic Neoplasms
18.
Int J Gynecol Pathol ; 36(1): 90-94, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27362904

ABSTRACT

Minimal-deviation endometrioid adenocarcinoma (MDEA) of the uterine cervix is a rare tumor that may be confused histologically with a number of benign lesions as well as other types of endocervical neoplasia. The histologic and immunohistochemical features of MDEA have been described in case reports and in small series, but correlation of these findings with ultrastructural examination has not been documented. Herein we report a 51-yr-old patient who underwent hysterectomy for menorrhagia and was found to have a clinically unsuspected, stage IB cervical MDEA. The light microscopic, immunohistochemical, and electron microscopic features of the tumor are described, with the most significant ultrastructural abnormality being the presence of abnormal cilia and ciliogenesis.


Subject(s)
Adenocarcinoma/diagnosis , Carcinoma, Endometrioid/diagnosis , Uterine Cervical Neoplasms/diagnosis , Adenocarcinoma/pathology , Adenocarcinoma/ultrastructure , Carcinoma, Endometrioid/pathology , Carcinoma, Endometrioid/ultrastructure , Cervix Uteri/pathology , Cervix Uteri/ultrastructure , Diagnosis, Differential , Female , Humans , Hysterectomy , Middle Aged , Uterine Cervical Neoplasms/pathology , Uterine Cervical Neoplasms/ultrastructure
19.
Cell Death Dis ; 7(9): e2372, 2016 09 22.
Article in English | MEDLINE | ID: mdl-27899819

ABSTRACT

Metastasis is a great challenge in lung adenocarcinoma (ADC) therapy. Cholesterol has been implicated in ADC metastasis. 4-cholesten-3-one, as cholesterol metabolite and analog, can substitute membrane cholesterol and increase membrane fluidity. In this study, we explored the possibility that 4-cholesten-3-one inhibited ADC metastasis. Low-dose 4-cholesten-3-one significantly restrained ADC cells migration and invasion with little effects on cells viabilities. Further investigation showed that 4-cholesten-3-one promoted ROS generation, which transiently activated AMPKα1, increased HIF1α expression, reduced Bcl-2 expression and caused autophagy. AMPKα1 knockdown partly suppressed 4-cholesten-3-one-induced autophagy but, neither prevented 4-cholesten-3-one-induced upregulation of HIF1α or downregulation of Bcl-2. 4-cholesten-3-one-induced autophagy facilitated the release of HMGB1 from nuclei to cytoplasm, blocking nuclear translocation of HIF1α and activation of MMP2 and MMP9. Also, 4-cholesten-3-one induced time-dependent phosphorylation of caveolin-1, Akt and NF-κB. With increasing treatment time, 4-cholesten-3-one accelerated caveolin-1 internalization, but reduced the phosphorylation of Akt and NF-κB, and inhibited the expression of snail and twist. These data suggested that 4-cholesten-3-one could be a potential candidate for anti-metastasis of lung adenocarcinoma.


Subject(s)
Adenocarcinoma/drug therapy , Adenocarcinoma/pathology , Caveolin 1/metabolism , Cholestenones/therapeutic use , HMGB1 Protein/metabolism , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Lung Neoplasms/drug therapy , Lung Neoplasms/pathology , Adenocarcinoma/metabolism , Adenocarcinoma/ultrastructure , Adenocarcinoma of Lung , Animals , Autophagy/drug effects , Brain Neoplasms/secondary , Cell Line, Tumor , Cell Movement/drug effects , Cell Proliferation/drug effects , Cell Survival/drug effects , Cholestenones/pharmacology , Cholesterol/metabolism , Endocytosis/drug effects , Lung Neoplasms/metabolism , Lung Neoplasms/ultrastructure , Male , Mice, Inbred BALB C , Mice, Nude , Models, Biological , Neoplasm Invasiveness , Phosphorylation/drug effects , Protein Transport/drug effects , Reactive Oxygen Species/metabolism , Signal Transduction/drug effects
20.
Respir Med ; 119: 175-179, 2016 10.
Article in English | MEDLINE | ID: mdl-27692141

ABSTRACT

RATIONALE: Hepatoid adenocarcinoma (HAC) is a rare malignant lung tumor that histologically resembles typical hepatocellular carcinoma (HCC) when it is metastatic to the lung. To date, this clinical entity has not been highlighted in the pulmonary literature. OBJECTIVE: We present a review of all known cases of HAC, including the relevant clinical and histopathological features important for pulmonologists. MEASUREMENTS AND MAIN RESULTS: The purpose of this report is to present a new case of HAC, with typical clinical and histologic features of this malignancy, and to summarize findings of previously reported cases. A systematic literature search of the electronic database PUBMED was conducted to identify all cases of hepatoid adenocarcinoma reported in the English literature, between January 1980 and June 2015. HAC and HCC can be distinguished by immunohistochemical staining. HAC usually presents as a large bulky solitary mass in the upper lobe; there is an exceedingly high prevalence in males and most patients with this tumor are smokers. Serum alpha-fetoprotein (AFP) in very high levels has been a distinguishing feature of this tumor. Nodal and distant metastases are common at initial presentation and, as a result, the prognosis is very poor. Resection and long-term survival, however, have been reported. CONCLUSION: Hepatoid adenocarcinoma, first described as a gastric tumor, has also been described in the lung. It morphologically resembles and must be distinguished from metastatic HCC of the lung. While most tumors produce AFP, the case we present demonstrates that this should not be a criterion for diagnosis.


Subject(s)
Adenocarcinoma/pathology , Carcinoma, Hepatocellular/pathology , Liver Neoplasms/pathology , Lung Neoplasms/pathology , Adenocarcinoma/immunology , Adenocarcinoma/surgery , Adenocarcinoma/ultrastructure , Adult , Aged , Aged, 80 and over , Carcinoma, Hepatocellular/immunology , Carcinoma, Hepatocellular/ultrastructure , Cough/diagnostic imaging , Diagnosis, Differential , Disease-Free Survival , Dyspnea/diagnostic imaging , Fatal Outcome , Female , Hemoptysis/diagnostic imaging , Humans , Liver Neoplasms/secondary , Lung Neoplasms/diagnostic imaging , Lung Neoplasms/surgery , Lung Neoplasms/ultrastructure , Male , Middle Aged , Prevalence , Prognosis , Rare Diseases , Smoking/adverse effects , Smoking/epidemiology , Stomach Neoplasms/pathology , Substance-Related Disorders , Tomography, X-Ray Computed/methods , alpha-Fetoproteins/analysis
SELECTION OF CITATIONS
SEARCH DETAIL